PCRX

insider transactions

Pacira BioSciences, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-63.7K

0 buy · 63.7K sell

Net value · 365d

-$1.5M

$0 in · $1.5M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 63.7K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 15, 26

Laura Brege

Director

$0

2.0K sh

Own New
Grant·A
Jun 15, 26

Laura Brege

Director

$0

3.8K sh

Own New
Sell·S
Jun 11, 26

Lauren Riker KEY

Senior Vice President, Finance · 10b5-1

$143.7K

6.1K sh · $23.50

Own -9%
Grant·A
Jun 10, 26

Thomas G Wiggans

Director

$0

32.7K sh

Own New
Grant·A
Jun 10, 26

Alethia Young

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Alethia Young

Director

$0

6.4K sh

Own +56%
Grant·A
Jun 10, 26

Michael J. Yang

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Michael J. Yang

Director

$0

6.4K sh

Own +48%
Grant·A
Jun 10, 26

Samit Hirawat

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Samit Hirawat

Director

$0

6.4K sh

Own New
Grant·A
Jun 10, 26

Mark Froimson

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Mark Froimson

Director

$0

6.4K sh

Own +32%
Grant·A
Jun 10, 26

Christopher Christie

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Christopher Christie

Director

$0

6.4K sh

Own +38%
Grant·A
Jun 10, 26

Laura Brege

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Laura Brege

Director

$0

6.4K sh

Own +27%
Grant·A
Jun 10, 26

Marcelo Bigal

Director

$0

10.9K sh

Own New
Grant·A
Jun 10, 26

Marcelo Bigal

Director

$0

6.4K sh

Own +56%
Grant·A
Jun 5, 26

Laura Brege

Director

$0

16.4K sh

Own New
Sell·S
Jun 4, 26

Kristen Williams

Chief Administrative Officer · 10b5-1

$228.5K

10.3K sh · $22.27

Own -6%
Other·F
Jun 3, 26

Lauren Riker KEY

Senior Vice President, Finance

$71.1K

3.2K sh · $22.32

Own -4%
Other·F
Jun 3, 26

Jonathan Slonin

Chief Medical Officer

$105.5K

4.7K sh · $22.32

Own -2%
Other·F
Jun 3, 26

Kristen Williams

Chief Administrative Officer · 10b5-1

$190.3K

8.5K sh · $22.32

Own -5%
Exercise·M
Apr 23, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$0

12.9K sh

Own +9%
Sell·S
Apr 23, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$325.6K

12.9K sh · $25.16

Own -11%
Exercise·M
Apr 23, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$212.9K

12.9K sh · $16.45

Own +12%
Exercise·M
Apr 22, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$0

1.5K sh

Own +1%
Sell·S
Apr 22, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$37.5K

1.5K sh · $25.01

Own -1%
Exercise·M
Apr 22, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$24.7K

1.5K sh · $16.45

Own +1%
Exercise·M
Apr 21, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$0

2.8K sh

Own +2%
Sell·S
Apr 21, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$71.2K

2.8K sh · $25.01

Own -3%
Exercise·M
Apr 21, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$46.8K

2.8K sh · $16.45

Own +3%
Exercise·M
Apr 20, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$0

7.7K sh

Own +5%
Sell·S
Apr 20, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$193.9K

7.7K sh · $25.14

Own -7%
Exercise·M
Apr 20, 26

Shawn Cross KEY

Chief Financial Officer · 10b5-1

$126.9K

7.7K sh · $16.45

Own +7%
Sell·S
Mar 17, 26

Jonathan Slonin

Chief Medical Officer · 10b5-1

$74.4K

3.3K sh · $22.82

Own -1%
Sell·S
Mar 17, 26

Mark Froimson

Director

$10.9K

500 sh · $21.81

Own -2%
Grant·A
Feb 11, 26

Kristen Williams

Chief Administrative Officer

$0

54.5K sh

Own +42%
Grant·A
Feb 11, 26

Brendan Teehan

Chief Commercial Officer

$0

51.7K sh

Own +105%
Grant·A
Feb 11, 26

Lauren Riker KEY

Senior Vice President, Finance

$0

19.3K sh

Own +37%
Grant·A
Feb 11, 26

Jonathan Slonin

Chief Medical Officer

$0

54.5K sh

Own +32%
Grant·A
Feb 11, 26

Frank D. Lee KEY

Chief Executive Officer

$0

261.8K sh

Own +66%
Grant·A
Feb 11, 26

Shawn Cross KEY

Chief Financial Officer

$0

49.1K sh

Own +87%
Sell·S
Feb 2, 26

Lauren Riker KEY

Senior Vice President, Finance · 10b5-1

$83.2K

4.0K sh · $20.81

Own -7%
Sell·S
Feb 2, 26

Kristen Williams

Chief Administrative Officer · 10b5-1

$269.7K

13.1K sh · $20.53

Own -9%
Other·F
Jan 30, 26

Lauren Riker KEY

Senior Vice President, Finance · 10b5-1

$56.5K

2.8K sh · $20.54

Own -5%
Other·F
Jan 30, 26

Kristen Williams

Chief Administrative Officer · 10b5-1

$351.9K

17.1K sh · $20.54

Own -11%
Other·F
Jan 30, 26

Jonathan Slonin

Chief Medical Officer

$126.7K

6.2K sh · $20.54

Own -3%
Other·F
Jan 30, 26

Brendan Teehan

Chief Commercial Officer

$106.4K

5.2K sh · $20.54

Own -10%
Other·F
Jan 30, 26

Frank D. Lee KEY

Chief Executive Officer

$852.2K

41.5K sh · $20.54

Own -9%
Grant·A
Jan 27, 26

Samit Hirawat

Director

$0

39.3K sh

Own New
Sell·S
Jan 5, 26

Lauren Riker KEY

Senior Vice President, Finance · 10b5-1

$34.3K

1.4K sh · $24.24

Own -2%
Other·F
Jan 2, 26

Jonathan Slonin

Chief Medical Officer

$9.3K

381 sh · $24.46

Own -0%
Other·F
Jan 2, 26

Lauren Riker KEY

Senior Vice President, Finance · 10b5-1

$3.9K

159 sh · $24.46

Own -0%
Other·F
Jan 2, 26

Frank D. Lee KEY

Chief Executive Officer

$226.8K

9.3K sh · $24.46

Own -2%
Grant·A
Dec 31, 25

Brendan Teehan

Chief Commercial Officer

$4.3K

402 sh · $10.76

Own +1%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 15, 2026	Laura Brege	Director	Grant A	2.0K	New	—	$0
Jun 15, 2026	Laura Brege	Director	Grant A	3.8K	New	—	$0
Jun 11, 2026	Lauren Riker KEY 10b5-1	Senior Vice President, Finance	Sell S	6.1K	-9%	$23.50	$143.7K
Jun 10, 2026	Thomas G Wiggans	Director	Grant A	32.7K	New	—	$0
Jun 10, 2026	Alethia Young	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Alethia Young	Director	Grant A	6.4K	+56%	—	$0
Jun 10, 2026	Michael J. Yang	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Michael J. Yang	Director	Grant A	6.4K	+48%	—	$0
Jun 10, 2026	Samit Hirawat	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Samit Hirawat	Director	Grant A	6.4K	New	—	$0
Jun 10, 2026	Mark Froimson	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Mark Froimson	Director	Grant A	6.4K	+32%	—	$0
Jun 10, 2026	Christopher Christie	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Christopher Christie	Director	Grant A	6.4K	+38%	—	$0
Jun 10, 2026	Laura Brege	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Laura Brege	Director	Grant A	6.4K	+27%	—	$0
Jun 10, 2026	Marcelo Bigal	Director	Grant A	10.9K	New	—	$0
Jun 10, 2026	Marcelo Bigal	Director	Grant A	6.4K	+56%	—	$0
Jun 5, 2026	Laura Brege	Director	Grant A	16.4K	New	—	$0
Jun 4, 2026	Kristen Williams 10b5-1	Chief Administrative Officer	Sell S	10.3K	-6%	$22.27	$228.5K
Jun 3, 2026	Lauren Riker KEY	Senior Vice President, Finance	Other F	3.2K	-4%	$22.32	$71.1K
Jun 3, 2026	Jonathan Slonin	Chief Medical Officer	Other F	4.7K	-2%	$22.32	$105.5K
Jun 3, 2026	Kristen Williams 10b5-1	Chief Administrative Officer	Other F	8.5K	-5%	$22.32	$190.3K
Apr 23, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	12.9K	+9%	—	$0
Apr 23, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Sell S	12.9K	-11%	$25.16	$325.6K
Apr 23, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	12.9K	+12%	$16.45	$212.9K
Apr 22, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	1.5K	+1%	—	$0
Apr 22, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Sell S	1.5K	-1%	$25.01	$37.5K
Apr 22, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	1.5K	+1%	$16.45	$24.7K
Apr 21, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	2.8K	+2%	—	$0
Apr 21, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Sell S	2.8K	-3%	$25.01	$71.2K
Apr 21, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	2.8K	+3%	$16.45	$46.8K
Apr 20, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	7.7K	+5%	—	$0
Apr 20, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Sell S	7.7K	-7%	$25.14	$193.9K
Apr 20, 2026	Shawn Cross KEY 10b5-1	Chief Financial Officer	Exercise M	7.7K	+7%	$16.45	$126.9K
Mar 17, 2026	Jonathan Slonin 10b5-1	Chief Medical Officer	Sell S	3.3K	-1%	$22.82	$74.4K
Mar 17, 2026	Mark Froimson	Director	Sell S	500	-2%	$21.81	$10.9K
Feb 11, 2026	Kristen Williams	Chief Administrative Officer	Grant A	54.5K	+42%	—	$0
Feb 11, 2026	Brendan Teehan	Chief Commercial Officer	Grant A	51.7K	+105%	—	$0
Feb 11, 2026	Lauren Riker KEY	Senior Vice President, Finance	Grant A	19.3K	+37%	—	$0
Feb 11, 2026	Jonathan Slonin	Chief Medical Officer	Grant A	54.5K	+32%	—	$0
Feb 11, 2026	Frank D. Lee KEY	Chief Executive Officer	Grant A	261.8K	+66%	—	$0
Feb 11, 2026	Shawn Cross KEY	Chief Financial Officer	Grant A	49.1K	+87%	—	$0
Feb 2, 2026	Lauren Riker KEY 10b5-1	Senior Vice President, Finance	Sell S	4.0K	-7%	$20.81	$83.2K
Feb 2, 2026	Kristen Williams 10b5-1	Chief Administrative Officer	Sell S	13.1K	-9%	$20.53	$269.7K
Jan 30, 2026	Lauren Riker KEY 10b5-1	Senior Vice President, Finance	Other F	2.8K	-5%	$20.54	$56.5K
Jan 30, 2026	Kristen Williams 10b5-1	Chief Administrative Officer	Other F	17.1K	-11%	$20.54	$351.9K
Jan 30, 2026	Jonathan Slonin	Chief Medical Officer	Other F	6.2K	-3%	$20.54	$126.7K
Jan 30, 2026	Brendan Teehan	Chief Commercial Officer	Other F	5.2K	-10%	$20.54	$106.4K
Jan 30, 2026	Frank D. Lee KEY	Chief Executive Officer	Other F	41.5K	-9%	$20.54	$852.2K
Jan 27, 2026	Samit Hirawat	Director	Grant A	39.3K	New	—	$0
Jan 5, 2026	Lauren Riker KEY 10b5-1	Senior Vice President, Finance	Sell S	1.4K	-2%	$24.24	$34.3K
Jan 2, 2026	Jonathan Slonin	Chief Medical Officer	Other F	381	-0%	$24.46	$9.3K
Jan 2, 2026	Lauren Riker KEY 10b5-1	Senior Vice President, Finance	Other F	159	-0%	$24.46	$3.9K
Jan 2, 2026	Frank D. Lee KEY	Chief Executive Officer	Other F	9.3K	-2%	$24.46	$226.8K
Dec 31, 2025	Brendan Teehan	Chief Commercial Officer	Grant A	402	+1%	$10.76	$4.3K

About PCRX insider trading

This page tracks insider transactions for Pacira BioSciences, Inc. (PCRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.